©The Author(s) 2025.
World J Gastroenterol. Dec 28, 2025; 31(48): 114049
Published online Dec 28, 2025. doi: 10.3748/wjg.v31.i48.114049
Published online Dec 28, 2025. doi: 10.3748/wjg.v31.i48.114049
Table 4 Comparisons between pediatric liver cirrhosis and adult liver cirrhosis, median (interquartile range)/n (%)/mean ± SD
| Variable | Pediatric (n = 62) | Adult (n = 69) | P value |
| Demographics | |||
| Age (years) | 11(4-14) | 43(34-46.5) | < 0.0001 |
| Sex | 0.9812 | ||
| Male | 54 (87.1) | 60 (87) | |
| Female | 8 (12.9) | 9 (13) | |
| Comorbidity | < 0.0001 | ||
| Hepatic encephalopathy | 0 (0) | 4 (5.8) | |
| Ascites | 4 (6.5) | 6 (8.7) | |
| Gastrointestinal bleeding | 0 (0) | 41 (59.4) | |
| Presenting symptoms of cirrhosis | < 0.0001 | ||
| Asymptomatic | 48 (77.4) | 8 (11.6) | |
| Fatigue | 3 (4.8) | 19 (27.5) | |
| Jaundice | 4 (6.5) | 3 (4.4) | |
| Abdominal discomfort | 6 (9.7) | 16 (23.2) | |
| Gastrointestinal bleeding | 2 (3.2) | 41 (59.4) | |
| Nausea | 0 (0) | 7 (10.1) | |
| Poor appetite | 4 (6.5) | 6 (8.7) | |
| Antiviral therapy before LC | 8 (12.9) | 35 (53.8) | < 0.0001 |
| History of self-discontinuation of antiviral therapy | 8 (12.9) | 8 (11.6) | 0.821 |
| Biochemistry | |||
| ALT (U/L) | 107.5 (58.5-207.25) | 29 (18-42) | < 0.0001 |
| AST (U/L) | 110.5 (64.25-169.5) | 39 (26-53.5) | < 0.0001 |
| GGT (U/L) | 70.5 (48-105) | 28 (18-46.5) | < 0.0001 |
| ALP (U/L) | 299 (232.25-373) | 70.5 (58-86) | < 0.0001 |
| ALB (g/L) | 39 (36-41.25) | 36 (32-38.5) | 0.0003 |
| TBIL (μmol/L) | 11.05 (8.1-19.15) | 11.9 (12.65-24.9) | 0.0002 |
| DBIL (μmol/L) | 4.7 (3.08-8.48) | 8.3 (5.3-11.25) | < 0.0001 |
| Glucose (mmol/L) | 4.5 (4.08-4.89) | 5 (4.26-6.29) | 0.004 |
| HDL-C (mmol/L) | 1.15 (0.97-1.4) | 1.83 (1.57-2.63) | 0.008 |
| LDL-C (mmol/L) | 2.27 (2.02-2.85) | 1.79 (1.56-2.56) | 0.0018 |
| TG (mmol/L) | 0.94 (0.75-1.28) | 0.78 (0.57-1.17) | 0.06226 |
| Cr (μmol/L) | 48.68 ± 14.11 | 75.61 ± 15.29 | < 0.0001 |
| HGB (g/L) | 127.84 ± 14.45 | 103.38 ± 22.29 | < 0.0001 |
| PLT (109/L) | 165 (113.5-221) | 91 (53.5-149) | 0.0072 |
| WBC (109/L) | 6.19 (4.67-7.62) | 7.24 (3.31-10.91) | 0.0062 |
| Lymphocyte (109/L) | 3.15(2.12-4.26) | 0.79 (0.55-1.49) | < 0.0001 |
| Neutrophil (109/L) | 3.175 (2.15-4.27) | 5.05 (2.14-9.18) | < 0.0001 |
| log10(qHBV DNA) | 6.3 (4.58-7.54) | 0 (0-5.43) | < 0.0001 |
| log10(qHBsAg) | 3.11 (0-3.69) | 5.19 (3-9.11) | 0.465 |
| HBeAg(+) | 48 (81.4) | 27 (39.1) | < 0.0001 |
| AFP (ng/mL) | 51 (13.73-255) | 3.97 (1.96-12.5) | 0.0261 |
| PT (seconds) | 12.3 (11.55-13.35) | 13.7 (12.9-15) | < 0.0001 |
| INR | 1.06 (0.99-1.14) | 1.18 (1.11-1.28) | < 0.0001 |
- Citation: Zhao BK, Li Y, Jiang YY, Li ML, Jiang Y, Zhu L, Guo CN, Liu SH, Chen L, Jiang LN, Niu JQ, Zhao JM. Clinical, pathological characteristics and long-term outcomes of hepatitis B virus related cirrhosis in pediatric observational study. World J Gastroenterol 2025; 31(48): 114049
- URL: https://www.wjgnet.com/1007-9327/full/v31/i48/114049.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i48.114049